Tag:
Sage Therapeutics
Latest Headlines
Latest Headlines
Third Rock bets $35M on upstart Sage Therapeutics in risky CNS market
Third Rock Ventures is taking its first shot on a biotech focused on the market for central nervous system ( CNS ) disorder drugs. The venture firm has fueled start-up Sage Therapeutics with a $35
